Transactions
7
Insider / AbbVie Inc.
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER at AbbVie Inc.
- Company
- AbbVie Inc.
- First filing on record
- February 20, 2026
- Latest trade on record
- May 6, 2026
- SEC filings
- EDGAR ↗
SALEKI-GERHARDT AZITA, EVP, CHIEF OPERATIONS OFFICER at AbbVie Inc., has disclosed 7 transactions in ENTG, ABBV since February 20, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $3.8M at the reported prices. The latest was filed May 8, 2026, 2 days after the trade.
Open-market buys
0
Sales
1
Avg. disclosure lag
2.3d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months SALEKI-GERHARDT AZITA made no purchases and 1 sale worth $3.8M, plus 6 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
SALEKI-GERHARDT AZITA has traded 1 stock on record; the largest by dollars is ABBV.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 6 | 58,535 | — |
| F | Shares withheld for tax | 1 | 16,309 | $3.8M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 7 | 0 | 1 · $3.8M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ENTG | Other A | May 6, 2026 | May 8, 2026 | 2d | 1,412 | — | — | Form 4 ↗ | ||
| ABBV | Sell F | February 27, 2026 | March 3, 2026 | 4d | 16,309 | $232 | $3.8M | Form 4 ↗ | ||
| ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 20,312 | — | — | derivative | Form 4 ↗ | |
| ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,638 | — | — | Form 4 ↗ | ||
| ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 7,074 | — | — | Form 4 ↗ | ||
| ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 6,058 | — | — | Form 4 ↗ | ||
| ABBV | Other A | February 18, 2026 | February 20, 2026 | 2d | 17,041 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 8, 2026 | Form 4 | 0001101302-26-000114 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0001563545-26-000004 | 1 | published | EDGAR ↗ |
| February 20, 2026 | Form 4 | 0001563545-26-000002 | 5 | published | EDGAR ↗ |
Other insiders at AbbVie Inc.
- LOY BERTRAND Director 34 rows
- Colella Joseph SVP and General Counsel 19 rows
- Hart Brett J Director 19 rows
- Blachier Olivier President, Materials Solutions 18 rows
- Siatis Perry C EVP, GC AND SECRETARY 16 rows
- Haris Clinton M. SVP & President, APS Division 15 rows
- Woodland Daniel D. SVP & President, MS Division 15 rows
- Rice Susan G. SVP, Global Human Resources 11 rows
- Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER 9 rows
- AUSTIN ROXANNE S Director 7 rows
Everyone on file, with contracts and lobbying under the company's name: AbbVie Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 7 | February 20, 2026 | May 8, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.